Based on these observations, it is reasonable to suggest that pharmacological approaches targeting leptin's effects could represent a potentially useful therapeutic strategy for the treatment of obesity-associated hypertension among other cardiovascular disease. This evidence concerns the gene LEP and Hypertension.